The sensitivities of three methods of detection of Mycoplasma pneumoniae by a 16S rDNA PCR were compared by using a serial dilution of M. pneumoniae. These methods consisted of a PCR performed directly on cells after a proteinase K pretreatment (direct PCR), a PCR after purification of nucleic acids (DNA-PCR), and a PCR with rRNA sequences as the target after reverse transcription. The direct PCR and the reverse transcription PCR had a sensitivity of 1.5 CFU (=250 genomes). By purification, a 10-fold loss of target DNA occurred, as shown by a 10-fold decrease in sensitivity (15 CFU) of the DNA-PCR. The presence of an excess of human background DNA did not influence the sensitivity of either PCR. The direct PCR was evaluated on samples from patients with respiratory complaints. Direct PCR amplification was possible in 94.9%o of the samples, which were tested by amplification of a 326-bp fament of the j-globin gene, which was performed to test for the suitability of amplification. Nucleic acid purification was performed on the P-globin-negative samples, after which only 2% remained negative. A positive correlation between the direct M. pneumoniae PCR and serology, as tested by the microparticle agglutination assay (MAG assay), was found in 88.1% of the cases. A positive MAG assay result was found for samples from 10 (17%) of the patients; samples from 6 (10.2%) of these patients were also positive by PCR. Samples from three patients were found to be positive by the M. pneumorniae PCR and negative by the MAG assay. Persistence ofM. pneumoniae, as detected by PCR, was observed in three patients. These results indicate that the direct PCR with 16S rDNA could prove to be useful in the detection of M. pneumoniae in respiratory tract samples, although more studies are needed to evaluate the correlation between clinical symptoms and a positive test result.
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Mycoplasma pneumoniae is a common cause of community-acquired respiratory tract infections, especially in children and young adults. Approximately 10% of the cases of community-acquired pneumonia that occur in endemic periods and up to 50% of the cases that occur in epidemic periods are caused byM. pneumoniae (5) . Rapid diagnosis of an M. pneumoniae infection is important, since M. pneumoniae is not sensitive to 3-lactam antibiotics, which are most often used empirically in the treatment of lower respiratory infections.
In routine laboratory practice, serology is used for the diagnosis of M. pneumoniae infections, since culture is relatively insensitive and 3 weeks or more may be required to obtain a result. In patients with primary infections, immunoglobulin M (IgM) can be detected from 7 days after the onset of symptoms and reaches a peak within 2 to 3 weeks. In patients with reinfections, IgM is mostly absent. Therefore, paired sera are used to confirm reinfection by M. pneumoniae, which is demonstrated by a fourfold rise in titer in IgG antibodies (13, 17) . This can be observed only when the first serum sample is taken within 10 days after the onset of disease (5). Sillis (17) showed that in the absence of IgM antibodies in patients with reinfections, IgA measurement in a single serum sample can be used for diagnosis. Thus, both in patients with primary infections and in patients with reinfections, serological diagnosis is not obtained before 1 week after the onset of symptoms.
Therefore, rapid direct tests such as antigen detection, hybridization with DNA probes, and recently, PCR have been developed. PCR seems to be the most promising direct technique because of its high sensitivity and specificity (4) . Different PCRs for the detection of M. pneumoniae have been described. The targets are the gene coding for the P1 adhesion protein, the 16S rRNA gene, and a DNA sequence specific for M. pneumoniae selected from a genomic library (1, 11, 20) . In different studies, the use of 16S rDNA sequences has been described for the detection of several microorganisms such as mycobacteria, Helicobacterpylori, and mycoplasmas (2, 10, 20) . The advantage of using 16S rRNA sequences is the high degree of conservation of the target and the presence of a high copy number of rRNA molecules in the cell, which are available as templates for the PCR after reverse transcription (RT) to DNA (RT-PCR). However, a disadvantage of an RT-PCR is the need for purification of RNA, making it less suitable for routine procedures. To date, a number of laboratories have successfully performed PCR directly on clinical material, after a simple pretreatment (direct PCR), for the detection of microorganisms (19, 21) .
To investigate the most sensitive and simple PCR for the detection of M. pneumoniae, a direct PCR, a PCR on purified DNA (DNA-PCR), and a RT-PCR were compared with PCR with either 16S rDNA or 16S rRNA as targets (20) . The optimal PCR method was compared with culture and serology in a study of 98 The following materials were collected from the respiratory tract: sputum (n = 25), throat (n = 42), and nasopharyngeal (n = 4) swabs; bronchial lavages (n = 24); nasopharyngeal aspirates (n = 2); and pleural fluid (n = 1). All samples were sent to the laboratory for routine culture of M. pneumoniae. A single serum sample was available from each of 34 patients, and at least two consecutive serum samples were available from 25 patients.
Culture. Both M. pneumoniae P84 and P71 were grown in SP4 broth. After a color change, the number of CFU was determined by culturing 100 pl of a 10-fold serial dilution on PPLO plates, which were subsequently incubated at 37°C in 5% CO2 for 2 weeks. After collection, throat or nasopharyngeal swabs were placed directly into 3 ml of SP4 broth. The swabs were twirled, expressed against the side of the tube, and discarded. Of the aspirate, lavage, and sputum samples, approximately 200 ,ul was put into 3 ml of SP4 broth after arrival at the laboratory. Highly viscous material was first made soluble by adding an equal volume of Sputolysin (Behring Diagnostics), and the mixture was vigorously shaken for 0.5 h on an automatic shaker (Marius, Utrecht, The Netherlands). Two milliliters of the broth was incubated at 37°C, and 200 ,ll was subsequently cultured on PPLO (37°C, 5% C02) plates either after a color change or blindly after 7 and 21 days of incubation. During the 3 weeks of incubation, the plates were checked twice weekly under an inverted microscope for the presence of Mycoplasma colonies. Identification of the Mycoplasma isolates was performed by the department of Mycoplasma Research, National Institute of Public Health and Environmental Protection. In addition, a small amount of a number of patient samples were cultured on modified Herderschee broth and agar and incubated at 37°C (95% N2 and 5% C02) by the National Institute of Public Health and Environmental Protection. Identification was done by identifying the colonies that appeared on the agar plates by indirect immunofluorescence by using specific polyclonal rabbit antibody for M. pneumoniae and horse anti-rabbit immunoglobulins labelled with fluorescein isothiocyanate.
Serology. A commercially available microparticle agglutination assay (MAG assay; Serodia Myco II; Fujirebio, Inc., Tokyo, Japan), which has been shown to be specific and sensitive for the diagnosis of M. pneumoniae infections (3) , and the complement fixation test were used as serological tests. Paired serum specimens were tested by the complement fixation test and the MAG assay; single serum samples were tested by the MAG assay only. An , and 2 pA of purified nucleic acids. This mixture was incubated for 1 h at 42°C. Only one-fourth of the RT reaction mixture was used in the PCR. The DNA PCR was performed on 2 ,u of diluted (four times) and purified nucleic acids, so that an equivalent amount of CFU was tested by each PCR method. Pretreatment of clinical samples. For the direct PCR, 200 pA of the SP4 broth inoculated with the clinical sample was centrifuged for 0.5 hour at 12,000 x g. Subsequently, the pellet was resuspended in 40 plA of Tris HCl (10 mM). Lysis buffer containing 500 p,g of proteinase K per ml, 0.45% Nonidet P-40, 0.45% Tween 20, 100 mM KCl, 20 mM Tris HCI, and 3 mM MgCl2 was added to a final volume of 100 pA. This solution was incubated overnight at 37.5°C, and the samples were subsequently boiled for 10 min to inactivate the proteinase K. The direct PCR was performed on 25 pl of this product.
PCR. The nucleotide sequences of the different primers used in the M. pneumoniae PCR (20) and the 0-globin PCR (15) are given in Table 1 . The specificity of the M. pneumoniae PCR has been tested extensively, as described by Van Kuppeveld et al. (20) . Under the conditions used, the primers amplified only M. pneumoniae but none of the other Mycoplasma species or other human pathogens (20 
RESULTS
Comparison of direct PCR versus RT-PCR. In order to compare the sensitivities of the different PCRs, each PCR was performed on a serial dilution of M. pneumoniae. The PCR was performed directly on cells by using a proteinase K treatment (direct PCR), after purification of nucleic acids (DNA-PCR), or after reverse transcription of rRNA (RT-PCR). The 277-bp fragment obtained from the M. pneumoniae PCR was produced with both strains P71 and P84, as detected on agarose gels and after hybridization with the probe. The absolute sensitivity of the direct PCR was 1.5 CFU on agarose gels. A 10-fold decrease in sensitivity was observed by the DNA-PCR. The RT-PCR restored the initially obtained sensitivity to 1.5 CFU (Table 2) . Additional hybridization did not lead to a higher sensitivity (Fig. 1) . The 4 of which were serologically positive and 3 only of which were PCR positive. Of the six patients whose samples were positive by both PCR and serology, samples from two patients were also found to be positive by culture. Serum from one patient whose sample was positive by PCR was not available, and cultures of the sample from the patient remained negative. More detailed results for the patients whose samples were positive by any of the tests are summarized in Table 4 and are described more extensively in the Discussion section.
DISCUSSION
Nucleic acid purification, which is often used as pretreat- (9) . Most likely for similar reasons, no improvement in sensitivity after hybridization was found, since this sensitivity was already reached at the gel level. A loss of DNA occurs during the purification step, as was shown by a 10-fold decrease in the sensitivity of the DNA-PCR compared with that of the direct PCR. This is in agreement with a study by Hammar et al. (8), who showed a decrease in sensitivity after each subsequent step in a purification procedure. Therefore, a purification method with a minimum of extraction and centrifugation steps, like the method of Gough (7), which has proved to be fast and reliable in our laboratory, is preferred. In conclusion, the results determined on an M. pneumoniae dilution series favor the direct PCR as the method of detecting M. pneumoniae in clinical samples because of its high sensitivity and relative simplicity.
To ensure that clinical samples were suitable for amplification, all were first tested by performing a PCR by amplifying a 326-bp fragment of the 0-globin gene. It is important that the 3-globin PCR amplifies a fragment comparable in length to the fragment amplified in the specific PCR, since smaller fragments have been found to be more efficiently amplified and less sensitive to the degradation of DNA (unpublished data). Negative ,3-globin results were found in only 5.1% (n = 5) of the samples by direct PCR and in 2% (n = 2) of the samples after purification of nucleic acids; this is in contrast to the 25% failure of amplification of ,3-globin found by Skakni et al. (18) . These findings might be explained by several differences between the studies, such as the use of different clinical samples, a ,-globin PCR with other primers, and a different pretreatment. All 0-globinnegative samples in the direct PCR were throat swabs. A negative PCR result could be the result of the small amount of DNA available in throat swab samples or inhibition. Amplification was successful in three of the five throat swab samples after purification of nucleic acids, indicating the removal of inhibitory factors.
The direct PCR for the detection of M. pneumoniae was evaluated on clinical samples by comparing the results obtained by the M. pneumoniae PCR with those obtained by culture and serology. The MAG assay and direct M. pneumoniae PCR yielded concordant results for samples from 88.1% of the patients (Table 3) . To exclude false-negative results obtained by the direct M. pneumoniae PCR, the RT-PCR was performed on a substantial part of samples negative by the direct M. pneumoniae PCR (data not shown). No additional positive samples were found in this group, which included a sample from a serologically positive patient. Although a good correlation was found between serology and PCR results, samples from seven patients gave discrepant results, as shown in Table 4 . A positive serological test with a negative PCR result was found for samples from four patients. M. pneumoniae was probably eradicated from two patients (patients 4 and 12), since samples for the state, such as three patients (patients 1, 3, and 6) in the present study in whom M. pneumoniae DNA was detected 3 weeks to 6 months after the start of the illness. M. pneumoniae DNA was also detected in two patients (patients 13 and 14) who clearly had other causes for their respiratory problems. Probably because of its high sensitivity, PCR is capable of detecting M. pneumoniae in circumstances other than acute infections. Therefore, PCR could be an attractive test for studying this persistence. On the other hand, it will prove difficult to correlate a positive PCR result with clinical symptoms if this persistence or carriage in healthy people is much more common then was presumed. The PCR could also prove useful in the diagnosis of extrapulmonary M. pneumoniae infections. Narita et al. (14) showed that M. pneumoniae DNA can be detected by PCR in the sera and cerebrospinal fluid of patients with clinical central nervous system infections. M. pneumoniae DNA in cerebrospinal fluid could be detected by the direct PCR described in the present study in a 9-year-old patient with high serological titers who died of encephalitis (data not shown). This patient and other serologically positive patients with symptoms of an central nervous system infection will be more extensively described in a future report.
In conclusion, the M. pneumoniae PCR directed at the 16S rRNA gene from respiratory tract samples after a simple pretreatment was found to be at least as sensitive and more practical than an RT-PCR. The RT-PCR was useful after nucleic acid purification, as indicated by the presence of PCR inhibition, since the improved sensitivity compensated for the loss of nucleic acids. Inhibition or loss of nucleic acids was encountered in only a small percentage of samples after a simple pretreatment protocol. Therefore, the direct 16S rRNA PCR proved to be valuable as a technique for detecting M. pneumoniae in respiratory tract samples, although future studies must be performed to evaluate the correlation between a positive PCR result and clinical symptoms. These investigations will be performed on samples from children with community-acquired respiratory infections.
